Michael P. Randall

Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma

Kristopher R. Bosse, Pichai Raman, Zhongyu Zhu et al. · Cancer Cell · 2017 · 222 citations · Full text

Oncogenic Agent, Immunology, Pathology +8

Wnt pathway activation by ADP-ribosylation

Eungi Yang, Ofelia Tacchelly‐Benites, Zhenghan Wang et al. · Nature Communications · 2016 · 72 citations · Full text

A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma

Annika Windon, Arturo Loaiza‐Bonilla, Christopher E. Jensen et al. · Journal of Gastrointestinal Oncology · 2018 · 61 citations · Full text

Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes

Yang Feng, Yanping Wang, Zhongyu Zhu et al. · mAbs · 2016 · 29 citations · Full text

Immunology, Cell Death, Immunologic Mechanism +19

Axin phosphorylation in both Wnt-off and Wnt-on states requires the tumor suppressor APC

Ofelia Tacchelly‐Benites, Zhenghan Wang, Eungi Yang et al. · PLoS Genetics · 2018 · 29 citations · Full text

Molecular Regulation, Cell Death, Axin Phosphorylation +23